$23.8 M

ACHV Mkt cap, 18-Apr-2019
Achieve Life Sciences Net income (FY, 2018)-12.7 M
Achieve Life Sciences Cash, 31-Dec-20189.5 M

Achieve Life Sciences Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

R&D expense

55.3m25.1m14.8m3.1m5.9m

General and administrative expense

9.9m11.8m8.9m3.5m6.9m

Operating expense total

65.2m36.9m26.3m6.6m12.8m

EBIT

(28.4m)

Interest income

150.0k119.0k203.0k21.0k171.0k

Pre tax profit

(13.6m)(12.7m)

Net Income

(31.8m)(16.8m)(20.1m)(10.6m)(12.7m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

R&D expense

18.0m16.9m9.9m9.6m3.7m6.5m8.3m4.6m4.7m3.8m912.0k777.0k825.0k1.2m1.0m1.5m

General and administrative expense

2.5m2.8m2.7m2.5m2.7m3.1m3.1m2.3m2.5m1.9m2.5m2.3m1.6m1.8m1.8m1.8m

Operating expense total

20.5m19.7m12.6m12.0m6.4m9.6m11.4m7.4m8.5m4.4m3.3m3.1m2.4m3.0m2.8m3.3m

Interest income

33.0k12.0k4.0k3.0k54.0k13.0k24.0k48.0k61.0k53.0k27.0k23.0k9.0k10.0k17.0k61.0k

Pre tax profit

(9.4m)(3.0m)(2.8m)(3.2m)

Net Income

(10.1m)(8.6m)(7.0m)(4.9m)(4.5m)(6.0m)(4.5m)(3.7m)(6.9m)(3.7m)(3.3m)(3.0m)(6.5m)(3.0m)(2.8m)(3.2m)

Achieve Life Sciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

14.6m27.9m34.3m15.2m5.3m9.5m

Accounts Receivable

218.0k113.0k111.0k32.0k

Inventories

Current Assets

53.9m55.8m57.3m26.9m5.9m15.5m

PP&E

397.0k257.0k602.0k258.0k59.0k35.0k

Goodwill

1.0m1.0m

Total Assets

55.7m56.3m58.2m27.5m9.9m19.1m

Accounts Payable

139.0k72.0k1.3m2.1m213.0k144.0k

Short-term debt

Current Liabilities

14.9m22.2m20.7m8.5m2.0m3.3m

Long-term debt

Total Debt

Total Liabilities

18.5m20.8m8.5m2.0m3.3m

Additional Paid-in Capital

168.2m191.4m211.6m213.2m20.6m41.2m

Retained Earnings

(133.7m)(160.0m)(176.8m)(196.9m)(12.7m)(25.4m)

Total Equity

37.2m37.4m19.0m7.9m15.8m

Financial Leverage

1.5 x1.6 x1.4 x1.3 x1.2 x

Achieve Life Sciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(31.8m)(26.2m)(16.8m)(20.1m)(10.6m)(12.7m)

Depreciation and Amortization

227.0k223.0k244.0k188.0k282.0k282.0k

Accounts Receivable

109.0k105.0k2.0k79.0k

Inventories

Accounts Payable

(1.2m)(67.0k)1.3m778.0k118.0k(69.0k)

Cash From Operating Activities

(35.9m)(17.3m)(9.1m)(29.7m)(9.1m)(10.6m)

Purchases of PP&E

(253.0k)(82.0k)(371.0k)(46.0k)(46.0k)

Cash From Investing Activities

32.4m5.4m(2.1m)10.6m12.6m(5.1m)

Cash From Financing Activities

10.0k25.2m17.6m(2.0k)2.0m19.8m

Achieve Life Sciences Ratios

USDY, 2018

Financial Leverage

1.2 x